Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Priya Life Science Clinical trial register
Trackers› Clinical trials› Hurstville
Clinical trial register · Australia

Clinical Trials in Hurstville, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Australia and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 3343 matching records held by the registry are in this view. Synced 15 Oct 2026, 03:18 UTC
3343
Studies in scope
all four open statuses
1804
Recruiting now
open to new participants
765
Lead sponsors
across recruiting studies
Top sites
Melbourne 1096 Adelaide 565 Sydney 508 Westmead 416 Clayton 407
Narrow the registerReset
Recruitment status
Phase
Site location
Melbourne1096 Adelaide565 Sydney508 Westmead416 Clayton407
All 401 locations
Target enrolment
to

Trials with a site in Hurstville

19 of 3343 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Australia
Start
Recruiting
Biojiva LLC
Phase 1/2
152
Albury, Baulkham Hills, Hurstville, Sydney, East Melbourne, Rowville
2026-09-29
Recruiting
Theratocular Biotek Co.
Phase 1/2
31
Hurstville, Sydney, Launceston
2026-06-02
Recruiting
A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-002)
NCT07440225Macular Degeneration, Age-Related Macular Degeneration, Choroidal Neovascularization, Wet Macular Degeneration
EyeBiotech Ltd.
Phase 2/3
960
Albury, Hurstville, Hurstville, Sydney, Launceston, Norwest, Parramatta, Strathfield, Sydney
2026-03-27
Recruiting
Phase 2 Study of ADX-038 in Participants With Geographic Atrophy
NCT06990269Geographic Atrophy Secondary to Age-related Macular Degeneration
ADARx Pharmaceuticals, Inc.
Phase 2
240
Albury, Hurstville, Parramatta, Sutherland, Sydney, East Melbourne, Rowville, Malvern
2025-11-10
Active, closed
A Study to Evaluate the Efficacy and Safety of Orally Administered VX-01
NCT06770933Diabetic Retinopathy, NPDR - Non Proliferative Diabetic Retinopathy
Vantage Biosciences Ltd
Phase 2
100
Albury, Hurstville, Parramatta, Sydney, Westmead, Birtinya, Adelaide
2025-02-11
Recruiting
Rigicon, Inc.
Not applicable
182
Auchenflower, Garran, Hornsby, Hurstville, Malvern, Miranda, Moorabbin
2025-01-16
Recruiting
Regeneron Pharmaceuticals
Phase 3
975
Albury, Hurstville, Strathfield, Adelaide, East Melbourne
2024-10-30
Active, closed
VIVEX Biologics, Inc.
Phase 2
121
Broadmeadow, Hurstville, Wahroonga, Wayville, Clayton
2024-10-04
Recruiting
A Randomized Trial of Five Fraction Partial Breast Irradiation (RAPID2)
NCT05417516Breast Neoplasm Female, Radiotherapy, Cosmetic Outcome
Ontario Clinical Oncology Group (OCOG)
Phase 3
910
Darlinghurst, Hurstville, North Sydney, Bundaberg, Southport, Tugun, Urraween, Adelaide
2023-11-20
Active, closed
McMaster University
Phase 4
446
Albury, Blacktown, Bondi Junction, Hurstville, Lane Cove, Liverpool, Parramatta, Strathfield
2023-05-01
Active, closed
A Real-World Study to Gain Clinical Insights Into Roche Ophthalmology Products
NCT05476926Neovascular Age-related Macular Degeneration, Diabetic Macular Edema, Retinal Vein Occlusion, Branch Retinal Vein Occlusion
Hoffmann-La Roche
Observational
6,000
Hurstville, Westmead, Geebung, East Melbourne, Melbourne, Rowville, Broome, Nedlands
2022-11-21
Active, closed
Biotronik, Inc.
Not applicable
60
Broadmeadow, Hurstville, Wahroonga, Noosa, Clayton
2021-09-20
Active, closed
Hoffmann-La Roche
Phase 3
451
Albury, Hurstville, Liverpool, Miranda, Sydney, Woolloongabba, East Melbourne, Rowville
2021-07-14
Active, closed
Darolutamide + Consolidation Radiotherapy in Advanced Prostate Cancer Detected by PSMA
NCT04319783Advanced Prostate Carcinoma, Cancer of Prostate, PSA, Castrate Resistant Prostate Cancer
Trans Tasman Radiation Oncology Group
Phase 2
65
Darlinghurst, Hurstville, Saint Leonards, Waratah, Herston, Raymond Terrace, Woolloongabba, Adelaide
2021-06-02
Recruiting
Saluda Medical Pty Ltd
Not applicable
200
Garran, Bella Vista, Broadmeadow, Charlestown, Hurstville, Newtown, Saint Leonards, St Leonards
2020-12-15
Active, closed
Janssen Pharmaceutica N.V., Belgium
Phase 3
691
Bundaberg, East Melbourne, Fitzroy, Hurstville, North Ryde, Waratah, Wembley
2020-11-12
Recruiting
Hoffmann-La Roche
Phase 3
1,000
Albury, Hurstville
2018-09-20
Recruiting
Boston Scientific Corporation
Observational
4,800
Auchenflower, Broadmeadow, Claremont, Hurstville, Noosa, Waurn Ponds, Wayville
2012-11-19
Recruiting
Patient Retrospective Outcomes (PRO)
NCT01550575Chronic Pain
Boston Scientific Corporation
Observational
15,000
Berwick, Broadmeadow, Caulfield South, Claremont, Hurstville, Noosa, Sydney, Wayville
2012-04-03
Rows per page Showing 1–19 of 19
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with an Australian investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 15 October 2026. https://priyalifescience.com/clinical-trials-australia/city/hurstville

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Australia and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 3,343 studies in total at the last sync on 15 Oct 2026, 03:18 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 19 of those studies with a site in Hurstville.

How many clinical trials are recruiting in Hurstville?

11 of the 19 studies on this page are recruiting new participants as of the 15 Oct 2026, 03:18 UTC sync. A further 0 have not yet opened recruitment, 8 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Hurstville), 19 studies
PhaseStudiesRecruitingShare
Phase 35326.3%
Phase 24121.1%
Not applicable3215.8%
Observational3215.8%
Phase 1/22210.5%
Phase 2/3115.3%
Phase 4105.3%

Most active sponsors

Lead sponsors with the most studies (Hurstville)
Lead sponsorStudiesRecruiting
Hoffmann-La Roche31
Boston Scientific Corporation22
ADARx Pharmaceuticals, Inc.11
Biojiva LLC11
Biotronik, Inc.10
EyeBiotech Ltd.11
Janssen Pharmaceutica N.V., Belgium10
McMaster University10
Ontario Clinical Oncology Group (OCOG)11
Regeneron Pharmaceuticals11
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.